The role of isoflavones in menopausal health: Consensus opinion of the North American Menopause Society

Menopause

Volumn 7, Issue 4, 2000, Pages 215-229

  Greenwood, S ^a   Barnes, S ^a   Clarkson, T B ^a   Eden, J ^a   Helferich, W G ^a   Hughes, C ^a   Messina, M ^a   Setchell, K D R ^a  

^a NONE   (United States)

Author keywords

Cancer; Hot flashes; Isoflavones; Lipids; Menopause; Soy

Indexed keywords

BIOCHANIN A; DAIDZEIN; FORMONONETIN; GENISTEIN; GLYCITEIN; HIGH DENSITY LIPOPROTEIN; ISOFLAVONE DERIVATIVE; LINSEED OIL; LOW DENSITY LIPOPROTEIN; PHYTOESTROGEN; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

AGING; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; EVIDENCE BASED MEDICINE; FEMALE; FOOD COMPOSITION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; NUTRITIONAL STATUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYMPTOMATOLOGY;

EID: 0033947805     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200007040-00003     Document Type: Review

References (117)

1. Boggs PP, Utian WH. The North American Menopause Society develops consensus opinions (editorial). Menopause 1998;5:67-8.
2. Mathieson RA, Kitts W. Binding of phytoestrogen and 17β-estradiol by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J Endocrinol 1980;85:317-25.
3. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cells. Endocrinology 1978;103:1860-7.
4. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63.
5. Peterson G, Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 1996;7:1345-51.
6. Salonieni H, Wahala K, Nykanen-Kurki P, Kallella K, Saastamoinen I. Phytoestrogen content and estrogenic effect of legume fodder. Proc Soc Exp Biol Med 1995;208:13-7.
7. Murphy PA. Phytoestrogen content of processed soybean products. Food Technol 1982;34:60-4.
8. Coward L, Barnes NC, Setchell KDR, et al. Genistein and daidzein, and their β-glycoside conjugates: anti-tumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7.
9. Dwyer JT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 1994;94:739-43.
10. Eldridge A, Kwolek WF. Soybean isoflavones: effect of environment and variety on composition. J Agric Food Chem 1983;31:394-6.
11. Barnes S, Kirk M, Coward L. Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem 1994;42:2466-74.
12. Wang HJ, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
13. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
14. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83:2223-35.
15. Barnes S. Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med 1998;217:386-92.
16. Klus K, Barz W. Formation of polyhydroxylated isoflavones from the soybean seed isoflavones daidzein and glycitein by bacteria isolated from tempe. Arch Microbiol 1995;164:428-34.
17. Setchell KDR. Phytoestrogens: the biochemistry, physiology, and implication for human health of isoflavones. Am J Clin Nutr 1998;68(Suppl):1333S-46S.
18. Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;129(Suppl):758S-67S.
19. Barnes S, Kim H, Peterson TG, et al. Isoflavones and cancer: the estrogen paradox. Korean Soybean Digest 1999;15:81-93.
20. Wang TTY, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996;17:271-5.
21. Tang GWK. The climacteric of Chinese factory workers. Maturitas 1994;19:177-82.
22. Burke GL. The potential use of a dietary soy supplement as a postmenopausal hormone replacement therapy. Presented at the Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Brussels, Belgium, September 15-18, 1996.
23. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.
24. Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995;21:189-95.
25. Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4:89-94.
26. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, de Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.
27. Upmalis D, Lobo R, Bradley L. Evaluation of the safety and efficacy of an oral soy extract in the treatment of vasomotor symptoms in menopausal women (abstract 30). Menopause 1999;6:327.
28. Nachtigall LB, Renichel R, LaGrega L, Lee WW, Nachtigall L. The effects of isoflavone derived from red clover on vasomotor symptoms, endometrial thickness, and reproductive hormone concentrations in menopausal women (abstract). Presented at the 81st Annual Meeting of the Endocrine Society, San Diego, CA, June 12-15, 1999.
29. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.
30. Harding C, Morton M, Gould V, et al. Dietary soy supplementation is estrogenic in menopausal women. Am J Clin Nutr (in press).
31. Dalais FS, Rice GE, Wahlquist ML, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998;1:124-9.
32. Baird DD, Umbach DM, Lansdell UL, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90.
33. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990;50(Suppl):3-12.
34. Register TC, Adams MR. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J Steroid Biochem Mol Biol 1998;64:187-91.
35. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafasson JA, Mendelsohn ME. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 1998;83:224-9.
36. Makela S, Savolainen H, Aavik E, et al. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci U S A 1999;96:7077-82.
37. Potter SM, Bakhit RM, Essex-Sorlie DL, et al. Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am J Clin Nutr 1993;58:501-6.
38. Bakhit RM, Klein BP, Essex-Sorlie D, Ham JO, Erdman JW Jr, Potter SM. Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations. J Nutr 1994;124:213-22.
39. Greaves KA, Parks JS, Williams JK, et al. Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J Nutr 1999;129:1585-92.
40. Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. ArteriosclerThromb Vasc Biol 1997;17:2524-31.
41. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997;17:3392-8.
42. Anderson JW, Johnstone BM, Cook-Newell ML. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.
43. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 1998;128:954-9.
44. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999;84:895-8.
45. Baber R, Clifton Bligh P, Fulcher G, Lieberman D, Nery L, Moreton T. The effect of an isoflavone dietary supplement (P-081) on serum lipids, forearm bone density and endometrial thickness in postmenopausal women (abstract 27). Menopause 1999;6:326.
46. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
47. Fang Z, Chen YF, Oparil S, Wyss JM. Induction of dietary NaCl-sensitive hypertension in female spontaneously hypertensive rats: role of estrogen (abstract). Hypertension 1999;34:336.
48. Hodgson JM, Puddey IB, Beilin LJ, et al. Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels: a randomized controlled trial. Am J Hypertens 1999;12:47-53.
49. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999;6:7-13.
50. Anthony MS, Clarkson TB. Comparison of soy phytoestrogens and conjugated equine estrogens on atherosclerosis progression in postmenopausal monkeys (abstract). Circulation 1998;97:829.
51. Dubey RK, Gillespie DG, Imthurn B, Rosselli M, Jackson EK, Keller PJ. Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension 1999;33:177-82.
52. Kapiotis S, Hermann M, Held I, Seelos C, Ehringer H, Gmeiner BM. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 1997;17:2868-74.
53. Fotsis T, Pepper M, Adlercreutz H, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A 1993;90:2690-4.
54. McGrath BP, Liang YL, Teede H, Shiel LM, Cameron JD, Dart A. Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy. Arterioscler Thromb Vasc Biol 1998;18:1149-56.
55. Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A 1998;95:3106-10.
56. Scheiber MD, Setchell KDR, Liu JH, Subbiah MTR, Rebar R. Dietary soy supplementation influences LDL oxidation and bone turnover in healthy postmenopausal women. Presented at the 81st Meeting of the Endocrine Society, San Diego, CA, June 1999.
57. Cummings SR, Cauley JA, Palermo L, et al. Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Osteoporos Int 1994;4:226-9.
58. Scheiber MD, Rebar RW. Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy? Menopause 1999;6:233-41.
59. Yoshida K, Tsukamoto T, Torii H, et al. Metabolism of ipriflavone (TC-80) in rats. Radioisotopes 1985;34:612-7.
60. Chen Z, Zheng W, Custer LJ, et al. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 1999;33:82-7.
61. Kimira M, Arai Y, Shimoi K, Watanabe S. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol 1998;8:168-75.
62. Anderson JJ, Ambrose WW, Garner SC. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 1998;217:345-50.
63. Ishida H, Uesugi T, Hirai K, et al. Preventive effect of the plant isoflavones, daidzein and genistein, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 1998;21:62-6.
64. Arjmandi BH, Birnbaum R, Toyal NV, et al. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 1998;68(Suppl):1364S-8S.
65. Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 1996;61:629-37.
66. Jayo MJ, Anthon MS, Register TC, et al. Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys (abstract 555). J Bone Miner Res 1996;11:S228.
67. Lees CJ, Ginn TA. Soy protein isolate diet does not prevent increased cortical bone turnover in ovariectomized macaques. Calcif Tissue Int 1998;62:557-8.
68. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(Suppl):1375S-9S.
69. The Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1996;276:1389-96.
70. Kohrt WM, Birge SJ. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women. Osteoporos Int 1995;5:150-5.
71. Vidal V, Kindblom LG, Ohlsson C. Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res 1999;14:923-9.
72. Nilsson IO, Boman A, Savendahl L, et al. Demonstration of estrogen receptor-beta immunoreactivity in human growth plate cartilage. J Clin Endocrinol Metab 1999;84:370-3.
73. Pansini F, Bonaccorsi G, Albertazl P, et al. Soy phytoestrogens and bone (abstract P-44). Menopause 1997;4:268.
74. St. Germain A, Hanson K, Peterson C, et al. Soy protein isolate with isoflavones prevents bone loss in the lumbar spine of perimenopausal women (abstract T385). Bone 1998;23(Suppl):S292.
75. Scheiber MD. The role of dietary phytoestrogens in reducing cardiovascular and osteoporotic risk factors in normal postmenopausal women. Research fellowship update report. Presented at the 9th Annual Meeting of The North American Menopause Society, Toronto, Ontario, Canada, September 17-19, 1998.
76. Gallagher JC, Rafferty K, Wilson M, Haynaska V. The effect of soy protein on bone metabolism. Presented at the Third International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Washington, DC, October 30-November 2, 1999.
77. Mackey R, Eden JA. Phytoestrogens. J Br Menopause Soc 1998(March);18-23.
78. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 1997;388:507-25.
79. Pan Y, Anthony M, Clarkson TB. Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med 1999;221:118-25.
80. Kim H, Xia H, Li L, Gewin J. Modulation of neurodegeneration markers by dietary soy in a primate model of menopause. Presented at the Third International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Washington, DC, October 30-November 2, 1999.
81. Hochanadel G, Shifren J, Zhdanova I, et al. Soy isoflavones (phytoestrogens) in the treatment of cognitive function and somatic symptoms of menopause (abstract). Pac Coast Reprod Soc 1999;20s:22.
82. White L, Petrovitch H, Ross GW, et al. Association of mid-life consumption of tofu with late life cognitive impairment and dementia: the Honolulu-Asia Aging Study (abstract 487). Neurobiol Aging 1996;17(Suppl):S121.
83. Rice MM, Graves ABA, Larson EB. Estrogen replacement therapy and cognition: role of phytoestrogens (abstract). Gerontologist 1995;35:169.
84. Rice MM, Graves AB, McCurry SM, et al. Tofu consumption and cognition in older Japanese American men and women. Presented at the Third International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Washington, DC, October 30-November 2, 1999.
85. Barnes S. Phytoestrogens and breast cancer. In: Adlercreutz H, ed. Phytoestrogens. Bailliere's Clin Endocrinol Metab 1998;12:559-80.
86. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991;83:541-6.
87. Li D, Yee JA, McGuire MH, Murphy PA, Yan L. Soybean isoflavones reduce experimental metastasis in mice. J Nutr 1999;129:1075-8.
88. Menon LG, Kuttan R, Nair MG, Chan YC, Kuttan G. Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr Cancer 1998;30:74-7.
89. Hargreaves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999;84:4017-24.
90. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997;350:990-4.
91. Messina M, Barnes S, Setchell K. Phyto-oestrogens and breast cancer (comment). Lancet 1997;350:971-2.
92. Wu AH, Ziegler RG, Horn-Ross PL, et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996;5:901-6.
93. Wu AH, Ziegler RG, Nomura AM, et al. Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr 1998;68(6 Suppl): 1437S-43S.
94. Lee HP, Gourley L, Duffy SW, et al. Dietary effects on breast-cancer risk in Singapore. Lancet 1991;337:1197-200.
95. Cassidy A, Bingham S, Setchell KDR. Biological effects of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
96. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1970;12:77-126.
97. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999;84:192-7.
98. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998;58:3833-8.
99. Fritz WA, Coward L, Wang J, Lamartiniere CA. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 1998;19:2151-8.
100. Barnes S, Grubbs C, Setchell KDR, et al. Soybeans inhibit mammary tumors in models of breast cancer. In: Pariza M, Liss AR, eds. Mutagens and carcinogens in the diet. New York: Alan R. Liss, 1990:239-53.
101. Hawrylewicz EJ, Huang HH, Blair WH. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 1991;121:1693-8.
102. Barnes S, Peterson TG, Grubbs C, et al. Potential role of dietary isoflavones in the prevention of cancer. In: Jacobs M, ed. Diet and cancer: markers, prevention, and treatment. New York: Plenum Press, 1994:135-48.
103. Lamartiniere CA, Murrill WB, Manzolillo PA, et al. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med 1998;217:358-64.
104. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, Lamartiniere CA. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 1996;17:1451-7.
105. Hawrylewicz EJ, Zapata JJ, Blair WH. Soy and experimental cancer: animal studies. J Nutr 1995;125(3 Suppl):698S-708S.
106. Constantinou AI, Mehta RG, Vaughan A. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 1996;16(6A):3293-8.
107. Gotoh T, Yamada K, Ito A, et al. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination. Japan J Cancer Res 1998;89:487-95.
108. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast secretion in pre-and postmenopausal women. CancerEpidemiol Biomarkers Prev 1996;5:785-94.
109. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998;68(6 Suppl):1431S-5S.
110. Whitten PL, Naftolin F. Reproductive actions of phytoestrogens. In: Adlercreutz H, ed. Phytoestrogens. Bailliere's Clin Endocrinol Metab 1998;12:667-90.
111. Parkin DM. Cancers of the breast, endometrium and ovary: geographic correlations. Eur J Cancer Clin Oncol 1989;25:1917-25.
112. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 1997;146:294-306.
113. Foth D, Cline JM. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 1998;68(6 Suppl):1413S-7S.
114. Theodorescu D, Laderoute KR, Calaoagan JM, Guilding KM. Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression. Int J Cancer 1998;78:775-82.
115. Zhou JR, Mukherjee P, Gugger ET, TanakaT, Blackburn GL, Clinton SK. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 1998;58:5231-8.
116. Uckun FM, Narla RK, Zeren T, et al. In vivo toxicity, pharmacokinetics, and anticancer activity of genistein linked to recombinant human epidermal growth factor. Clin Cancer Res 1998;4:1125-34.
117. Uckun FM, Evans WE, Forsyth CJ, et al. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995;267:886-91.